Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganirelix vs Triptorelin for Controlled Ovarian Stimulation in Chinese Women
NCT00725491Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Peptides, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of ganirelix in female infertility (2 arms), sponsored by Organon & Co. Primary endpoint: Amount of International Units (IU) of Recombinant Follicle Stimulating Hormone (recFSH) Needed in a Controlled Ovarian Stimulation (COS) Cycle up to 18 days. Started May 2007; status: completed.
02
Drugs
ganirelix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT00725491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725491.